ANIK News 42.06 08/01/2014 04:34:13 Anika Therapeutics Inc (

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Anika Therapeutics Inc (ANIK) 42.06 $ANIK

Nasdaq stocks posting largest percentage decreases
AP - Thu Jul 31, 5:04PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:

Major Indexes Extend Losses; S&P 500 Breaks 50-Day Line
at Investor's Business Daily - Thu Jul 31, 10:50AM CDT
Stocks lost more ground near the midpoint of Thursday's session. They had been under pressure from the start amid Argentina's debt default and mixed economic data. The Nasdaq slumped 1.6%, hurt by software and chip stocks. The S&P 500 dropped 1.3%,...

Anika Therapeutics partners with Medline for marketing of wound care product Hyalomatrix
M2 - Thu Jul 31, 6:15AM CDT
Therapeutic products company Anika Therapeutics (NasdaqGS:ANIK) reported on Wednesday the execution of an exclusive agreement to commercialise its Hyalomatrix in the US in partnership with Medline Industries

ANIKA THERAPEUTICS
at Investor's Business Daily - Wed Jul 30, 6:03PM CDT
ANIKA THERAPEUTICS (ANIK), a bone-healing product maker, said Q2 EPS rose 50% to 60 cents, beating by 3 cents. Sales increased 26% to $26.3 mil, but missed views for $28.2 mil. Shares fell 6.5% to 46.50.

Anika Therapeutics Reports Second-Quarter 2014 Financial Results
Business Wire - Wed Jul 30, 3:05PM CDT
--Commercial Launch of Monovisc(R) Generates $5 Million Milestone Payment

Anika Therapeutics Announces U.S. Commercialization Partnership for Hyalomatrix(R) with Wound Care Leader Medline Industries, Inc.
Business Wire - Wed Jul 30, 12:04PM CDT
Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that it has entered into a new agreement with Medline Industries, Inc. to commercialize the Company's advanced wound care product - Hyalomatrix(R), in the United States on an exclusive basis through 2019. According to the agreement, Anika will receive product payment and royalty revenues from the sale of the product by Medline. Hyalomatrix(R) is a biologically-derived matrix for in-growing cells, and has the U.S. Food and Drug Administration marketing clearance.

Anika Therapeutics Up 36.4% Since SmarTrend Uptrend Call (ANIK)
Comtex SmarTrend(R) - Mon Jul 28, 5:06PM CDT
SmarTrend identified an Uptrend for Anika Therapeutics (NASDAQ:ANIK) on February 21st, 2014 at $34.67. In approximately 5 months, Anika Therapeutics has returned 36.35% as of today's recent price of $47.28.

Scheduled Conference Calls and Product Launches - Research Reports on Anika Therapeutics, NeoGenomics, HeartWare, Sangamo and Dyax
PR Newswire - Wed Jul 23, 7:40AM CDT
Today, Analysts Review released its research reports regarding Anika Therapeutics, Inc. (NASDAQ: ANIK), NeoGenomics, Inc. (NASDAQ: NEO), HeartWare International Inc (NASDAQ: TWR), Sangamo BioSciences, Inc. (NASDAQ: SGMO) and Dyax Corp (NASDAQ: DYAX). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/5011-100free.

Global Hyaluronic Acid Products (Single-Injection, Three-Injection Cycle and Five-Injection Cycle) Market 2014-2019
M2 - Mon Jul 21, 3:50AM CDT
Research and Markets (http://www.researchandmarkets.com/research/6ct2qw/hyaluronic_acid) has announced the addition of the "Global Hyaluronic Acid Products (Single-Injection, Three-Injection Cycle and Five-Injection Cycle) Market 2014-2019" report to their offering. Hyaluronic acid (HA) is a glycosaminoglycan that helps in transportation of nutrients through the body and facilitate water retention in body tissue. It is naturally found in body - in joints, eye cavity, immune system and others. HA was observed to be an important component of articular cartilage where it is present in the form of a coat around each chondrocyte. This report studies the global hyaluronic acid products market by types of products, applications and the major geographic markets. Products market is segmented as single-injection, three-injection cycle and five-injection cycle. Similarly, applications market is segmented as osteoarthritis, ophthalmic surgery, dermal fillers and vesicoureteral reflux (VUR). The market overview section of the hyaluronic acid products market report discusses the market dynamics with respect to market drivers, restraints and opportunities. This section also covers market attractiveness analysis (by geography) and Porter's five forces analysis for the global hyaluronic acid products market. Market share (%) for the major players operating in this market has also been provided for the year 2012, followed by a list of recommendations for the existing and new players to enter and enhance their market shares. The report concludes with the company profiles of key players operating in various segments of the market. Each company profile includes the business overview, financial overview, product portfolio, business strategies and recent developments of the respective company. Some of the prominent players in the hyaluronic acid products market that have been profiled in this report include Allegran Inc., Anika Therapeutics, Inc., Merz Aesthetics, Inc., Sanofi (Genzyme) and Seikagaku. The global hyaluronic acid products market is segmented as follows: Hyaluronic Acid Products Market, by Products - Single-injection - Three-injection cycle - Five-injection cycle Hyaluronic Acid Products Market, by Applications - Osteoarthritis - Ophthalmic - Dermal Fillers - Vesicoureteral Reflux (VUR) Key Topics Covered: Chapter 1 Introduction Chapter 2 Executive Summary Chapter 3 Market Overview Chapter 4 Global Hyaluronic Acid Products Market, by Products Chapter 5 Global Hyaluronic Acid Products Market, by Applications Chapter 6 Global Hyaluronic Acid Products Market, by Geography Chapter 7 Recommendations Chapter 8 Company Profiles - Alcon, Inc. - Allergan, Inc. - Anika Therapeutics, Inc. - F. Hoffmann-La Roche Ltd. - Ferring Pharmaceuticals, Inc. - Fidia Farmaceutici SpA - GALDERMA S.A. - Hyaltech Ltd. - LifeCore Biomedical LLC, - Meiji Seika Pharma Co., Ltd. - Merz Aesthetics, Inc. - Sanofi - Salix Pharmaceuticals, Inc. - Seikagaku Corporation - Shanghai Jingfeng Pharmaceutical Co., Ltd. - Smith & Nephew plc - TRB CHEMEDICA INTERNATIONAL SA - Zimmer Holdings, Inc. For more information visit http://www.researchandmarkets.com/research/6c...ronic_acid

Anika Therapeutics Announces Date of Second-Quarter 2014 Financial Results Conference Call
Business Wire - Tue Jul 15, 3:05PM CDT
Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that it plans to issue its second-quarter 2014 financial results after the close of the market on Wednesday, July 30, 2014. The company plans to hold a conference call the next day, Thursday, July 31 at 9:00 a.m. ET to discuss its financial results, business highlights and outlook. In addition, the company will answer questions concerning business and financial developments and trends, and other business and financial matters affecting the company, some of the responses to which may contain information that has not been previously disclosed.

44.4% Return Seen to Date on SmarTrend Anika Therapeutics Call (ANIK)
Comtex SmarTrend(R) - Mon Jul 14, 9:40AM CDT
SmarTrend identified an Uptrend for Anika Therapeutics (NASDAQ:ANIK) on February 21st, 2014 at $34.68. In approximately 5 months, Anika Therapeutics has returned 44.37% as of today's recent price of $50.06.

Biotech Stocks Gilead, Anika Still Near Buy Points
at Investor's Business Daily - Mon Jul 07, 4:39PM CDT
Biotechs Gilead Sciences (GILD) and Anika Therapeutics (ANIK) are among just a few stocks in the Spotlight screen that are still hovering near buy points. Anika, which makes treatments for tissue protection, healing and repair, cleared a 49.47 buy...

Uptrend Call Working As Anika Therapeutics Stock Rises 41.6% (ANIK)
Comtex SmarTrend(R) - Mon Jul 07, 9:20AM CDT
SmarTrend identified an Uptrend for Anika Therapeutics (NASDAQ:ANIK) on February 21st, 2014 at $34.68. In approximately 5 months, Anika Therapeutics has returned 41.60% as of today's recent price of $49.10.

Appointments, Acquisitions, Study Results, and Technical Updates - Analyst Notes on Alere, AMRI, Anika Therapeutics, Nektar and Sangamo
PR Newswire - Fri Jul 04, 5:30AM CDT
Today, Analysts Review released its analysts' notes regarding Alere Inc. (NYSE: ALR), Albany Molecular Research Inc. (NASDAQ: AMRI), Anika Therapeutics Inc. (NASDAQ: ANIK), Nektar Therapeutics (NASDAQ: NKTR) and Sangamo Biosciences Inc. (NASDAQ: SGMO). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/4465-100free.

35.5% Return Seen to Date on SmarTrend Anika Therapeutics Call (ANIK)
Comtex SmarTrend(R) - Fri Jun 27, 9:12AM CDT
SmarTrend identified an Uptrend for Anika Therapeutics (NASDAQ:ANIK) on February 21st, 2014 at $34.68. In approximately 4 months, Anika Therapeutics has returned 35.54% as of today's recent price of $47.00.

Anika Therapeutics Has Returned 31.8% Since SmarTrend Recommendation (ANIK)
Comtex SmarTrend(R) - Thu Jun 19, 4:50PM CDT
SmarTrend identified an Uptrend for Anika Therapeutics (NASDAQ:ANIK) on February 21st, 2014 at $34.68. In approximately 4 months, Anika Therapeutics has returned 31.77% as of today's recent price of $45.69.

Pricing of Offering, FDA Approvals, Launches, and Technical Updates - Analyst Notes on Tenet, Lannett, Wright Medical Group, Anika Therapeutics and Accuray
PR Newswire - Thu Jun 19, 5:00AM CDT
Today, Analysts Review released its analysts' notes regarding Tenet Healthcare Corp. (NYSE: THC), Lannett Company, Inc. (NYSE: LCI), Wright Medical Group Inc. (NASDAQ: WMGI), Anika Therapeutics Inc. (NASDAQ: ANIK) and Accuray Incorporated (NASDAQ: ARAY). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/3879-100free.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

America's Group Adds Swansea to Its UK Auction Map

Updated Category News Views 19

A Welsh Lane Joins a Larger Road Port Talbot just became a small but telling dot on America's Group's international map. The company has acquired Swansea Motor Vehicle Auction Limited, a long-standing South Wales wholesale and remarketing operation, and plans to run it under the G3 brand. This is not the sort of deal that makes markets levitate. It is the sort that tells...

Continue Reading
Mantle's Japan Listing Puts $MNT Through a Real Test

Updated Category News Views 88

Japan's crypto gatekeepers just handed Mantle a key, not a crown. The November 18 listing of $MNT on GMO Coin is a meaningful operational win because getting onto a Japanese centralized exchange is not the usual loose-change exercise seen in friendlier jurisdictions. Mantle cleared a review process involving GMO Coin and the Japan Virtual and Crypto Assets Exchange...

Continue Reading
Xailient Tops NIST for Real-World AI Face Recognition

Updated Category News Views 87

In a world where bigger ain't always better, Xailient's latest triumph at NIST's face recognition test has set them apart. On November 17, 2026, the U.S. National Institute of Standards and Technology (NIST) crowned Xailient as the leader in face recognition accuracy for on-device AI, leaving 105 others in the dust. This ain't your run-of-the-mill achievement—it shows...

Continue Reading
AES Clears FERC, Nearing Its December 2 Takeover Close

Updated Category News Views 119

One more regulatory gate just swung open for AES, and this deal is finally staring at the finish line instead of wandering through the usual approval swamp. The Federal Energy Regulatory Commission has issued its final order approving AES's acquisition by a consortium led by Global Infrastructure Partners, part of BlackRock, and EQT Infrastructure VI. The last major...

Continue Reading
Triple Crossing Tests a Tough Inland Marine Market

Updated Category News Views 150

Inland marine is where tidy insurance appetites go to get bent out of shape. A contractor’s rented machine, cargo moving between points, a half-finished building, or equipment that is neither parked forever nor easy to classify can turn a standard quote into a week of broker phone calls. Triple Crossing Specialty is stepping directly into that mess, launching a new...

Continue Reading
ELEGOO's Formnext Push Tests a Broader 3D Ambition

Updated Category News Views 123

Frankfurt’s show floor is where product promises meet some very unforgiving eyeballs. ELEGOO arrived at Formnext 2026 with more than a refreshed machine or two: it is laying out a wider bet across resin printing, FDM printing, and 3D scanning. That matters because the company is no longer presenting itself as merely a supplier of affordable creator hardware. It wants to...

Continue Reading
Animal Parasite Market Growth Has a Resistance Catch

Updated Category News Views 156

Flea collars and cattle worms do not sound glamorous, yet this is exactly where durable animal-health revenue gets built. Wissen Research puts the global animal parasiticides market at $13.6 billion in 2026 and projects $18.6 billion by 2031, a 6.5% compound annual growth rate. That is respectable, not moonshot stuff, and frankly that is part of the appeal. Pet owners...

Continue Reading
Stitch AI Targets Banking’s Hardest Automation Gap

Updated Category News Views 15

The flashy chatbot stuff is cheap; banking permission to act is not. That is why Stitch AI’s launch deserves more attention than another vendor slapping “agentic” on a slide deck and calling it transformation. Banks do not need a machine to summarize a policy document while everyone applauds the demo. They need technology that can touch real workflows without...

Continue Reading
Dolby's Strong Quarter Meets a Flat 2027 Reality Check

Updated Category News Views 81

A licensing machine just coughed up a very good quarter, then told investors not to expect the engine to accelerate next year. That is the whole Dolby story in one uncomfortable breath. NYSE:DLB finished fiscal 2026 with fourth-quarter revenue of $374 million, up from $307 million a year earlier, while GAAP diluted earnings climbed to $0.86 from $0.51. Those are not...

Continue Reading
Thoughts Unleashed Arrives With a Personal American Voice

Updated Category News Views 114

A lifetime of observation finally gets its own page Forty is an unusual age to begin writing poetry, which is exactly why Joyce Ann Grooms McGeehan's debut has a little more texture than the usual polished promise of inspiration. Thoughts Unleashed by an Independent, American Woman comes from someone who spent decades teaching French, English, and ESL, then retired to a...

Continue Reading

Top 5 Most Recently Viewed Articles

Exciting Changes in Leadership Position at ibex Limited

Updated Category News Views 289

Board of Directors' Transformation at ibex Limited ibex Limited, a prominent player in global business process outsourcing, has recently made significant changes to its Board of Directors. The company announced that Gerard Kleisterlee will retire from his position after the upcoming Annual General Meeting (AGM). A Fond Farewell to Gerard Kleisterlee Gerard has been an...

Continue Reading
Umicore's Shareholding Update: Impact and Insights

Updated Category News Views 148

Investor Transparency Notification from Silchester International Investors LLP Transparency notification by Silchester International Investors LLP Umicore has recently received a significant transparency notification regarding shareholding changes from Silchester International Investors LLP. This notification falls under the legal obligations concerning major holdings as...

Continue Reading
Exploring the Future of Retail at Digital Retail Africa 2025

Updated Category News Views 212

Event Overview of Digital Retail Africa 2025 The retail landscape is experiencing significant change, and Digital Retail Africa 2025 aims to prepare businesses for the rapidly evolving challenges and opportunities that lie ahead. This influential event, scheduled for January 30, 2025, at a premier venue, will gather top industry professionals, innovators, and...

Continue Reading
Understanding the Impact of Wegovy's Medicare Negotiation

Updated Category News Views 362

Implications of Wegovy's Medicare Price Negotiation The recent announcement regarding Medicare's negotiations for prescription medications has sparked considerable interest, particularly with the inclusion of Novo Nordisk's (NYSE: NVO) groundbreaking weight-loss drug, Wegovy. This decision marks a significant moment for both healthcare providers and patients across the...

Continue Reading
Max Stock Ltd. Receives Resignation News from Deputy CEO

Updated Category News Views 289

Max Stock Ltd. Announces Resignation of Deputy CEO Max Stock Limited (TASE: MAXO) has revealed that Mr. Nir Dagan, the Company’s Deputy CEO and Head of Finance, has decided to resign after nine impactful years of service. Mr. Dagan will remain in his position until the end of the calendar year. The Company appreciates Mr. Dagan’s extensive contribution over the years,...

Continue Reading